Nuray Bozkurt, Mertihan Kurdoglu, Zehra Kurdoglu, Fatma Kutlusoy, Kutay Biberoglu
Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2010;22(12):1144-50
PMID: 19916712
OBJECTIVE
To determine the advantages and disadvantages of the use of diclofenac sodium instead of meperidine for postcesarean section pain control.
METHODS
A total of 130 patients who had undergone cesarean section at the Department of Obstetrics and Gynecology of Gazi University Hospital were prospectively randomised to receive one of two postoperative pain control regimens. The first group of patients received intramuscular diclofenac sodium at a dose of 2 x 75 mg and additional breakthrough meperidine was given intramuscularly at 50 mg dosages each time, if necessary. Patients in the second group received only 6 x 50 mg meperidine.
RESULTS
Twenty-seven of the 65 patients in the diclofenac group complained of unrelieved pain within the subsequent 24 h postoperatively. Patients receiving diclofenac alone or a combination of diclofenac + meperidine were less sedated and the time to the first passing of flatus was shorter than that in the patients treated with only meperidine.
CONCLUSIONS
Diclofenac alone was safe and effective for the majority of the patients and it decreased the opioid requirements in the remaining patients.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.